Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Arrangement for the discharge of exhaust air separated from the lubricating oil de-aeration system of a gas-turbine engine
Peptide epitopes of apolipoprotein B
Comparison selection, ranking, and anti-cheating methods in an online contest environment
Conjugated diene polymer, process for its production and rubber compositions containing the same
Biologically active compound N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride with anti-inflammatory activity
System and method for cooling a nozzle
Display screen with animated graphical user interface
  Randomly Featured Patents
System and method of prior image constrained image reconstruction using short scan image data and objective function minimization
Working fluids for an absorption cooling system
Insulators with increased surface conductivity and method for increasing the conductivity on surfaces of insulators having high electrical resistance made of inorganic and organic materials su
Apparatus for distributed bone growth stimulation
System and method for dispersion compensation in an optical communication system
Voltage/current control system for a human tissue stimulator
Method for inspecting fat-soluble vitamin and/or fat-soluble food factor by saliva analysis
Optical lens on wafer level and related method for forming the optical lens one wafer level
Mounting arrangement for the pivotally openable rudder blades of a guided missile
Timing device